Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease (Contemporary Cardiology) - Image 1

£102.54

Humana Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease (Contemporary Cardiology)

Name: Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease (Contemporary Cardiology)
Brand: Humana
Price: 102.54 GBP
Availability: InStock

Cardiovascular

This is the usual price. Wait for it to drop, or tell us your number.

£103 today · usual range £0–£0 · best ever £21

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 602 days • 552 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 602 days • 2 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £94-112 (537 days, 97.3%)

Price range: £21 - £112

Price levels: 2 price ranges over 552 days

Description

One of the most important developments in the field of cardiovascular medicine over the last two decades has been recognition of the key role played by arterial thrombosis in the pathogenesis of acute coronary syndromes, ischemic complications of percutane ous coronary revascularization, and coronary and peripheral atherosclerosis. The phar macologic armamentarium directed against vascular thrombosis has thus expanded substantially during that time, with development of new fibrinolytic agents, low-molecu lar-weight heparins, direct thrombin inhibitors, antagonists to platelet activation, and the platelet glycoprotein lIb/IlIa inhibitors. Though clinical investigations of these com pounds have been marked by failures as well as successes, there is little doubt that enhanced antithrombotic therapies have markedly improved the outcome of patients undergoing coronary revascularization or with acute coronary syndromes. Glycoprotein IIblIlIa receptor antagonists were introduced into clinical practice to overcome the limitations of approaches that inhibit only individual pathways of platelet activation. Multiple mechanisms of platelet activation in response to different agonists converge on the platelet membrane glycoprotein IIblIlIa complex, the "final common pathway" of platelet aggregation. The clinical hemorrhagic syndrome caused by a rare inherited defect in this receptor (Glanzmann' s thrombasthenia), characterized by muco cutaneous and postsurgical bleeding, but infrequent spontaneous organ (particularly central nervous system) bleeding, suggested that therapeutic inhibition of this receptor might be a potent, yet well-tolerated means of treating thrombotic disorders.

Product Specifications

Brand: Humana
Format: hardcover
ASIN: 1588291855
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Cardiovascular
Domain: Amazon UK
Release Date: 07 March 2003
Listed Since: 05 January 2007

Barcode

No barcode data available

Humana Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease (Contemporary Cardiology)

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

XIVth International Symposium on Medicinal Chemistry: Proceedings : Maastricht, the Netherlands, 8-12 September 1996 (Pharmacochemistry Library): Volume 28

Platelet Function: Assessment, Diagnosis, and Treatment (Contemporary Cardiology)

Platelets in Cardiovascular Disease

Antiplatelet Agents: 210 (Handbook of Experimental Pharmacology, 210)

Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease (Contemporary Cardiology)

Antiplatelet Agents: 210 (Handbook of Experimental Pharmacology, 210)

Hemostasis and Thrombosis: Basic Principles and Clinical Practice

Platelets, Haemostasis and Inflammation: 5 (Cardiac and Vascular Biology, 5)

Plasminogen–Related Growth Factors: v.212 (Novartis Foundation Symposia)

Platelets, Thrombosis and the Vessel Wall: 6 (Advances in Vascular Biology)

Hemostasis and Thrombosis: Methods and Protocols: 1646 (Methods in Molecular Biology, 1646)

Platelets in Hematologic and Cardiovascular Disorders: A Clinical Handbook

Clopidogrel and the Newer P2Y12 Antiplatelet Agents: Pharmacology, Clinical Uses, and Adverse Effects

Handbook of Platelet Physiology and Pharmacology

The Coagulation Consult: A Case-Based Guide

The Coagulation Consult: A Case-Based Guide

Platelet Protocols: Research and Clinical Laboratory Procedures

Practical Hemostasis and Thrombosis

Laboratory Techniques in Thrombosis ― a Manual (2nd Revised Edition of Ecat Assay Procedures)

Thrombosis and Thromboembolism: 44 (Fundamental and Clinical Cardiology)

Essential Guide to Blood Coagulation, 2nd Edition

Detection of anti-ADAMTS13 antibodies in patients with TTP: Characterization of the immune response against ADAMTS13 in patients with thrombotic thrombocytopenic purpura

Recent Advances in Thrombosis and Hemostasis

Platelets, Haemostasis and Inflammation (Cardiac and Vascular Biology)